Pharmacokinetics of tobramycin in the newborn
β Scribed by H. Yoshioka; M. Takimoto; K. Fujita; S. Maruyama
- Publisher
- Springer-Verlag
- Year
- 1979
- Tongue
- English
- Weight
- 317 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0300-8126
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Peak and trough serum concentrations of ceftazidime and tobramycin were determined in neonates with suspected septicaemia in an open randomized study. Mean peak serum levels were 85 (+/- 4.4 SE) mg/l for ceftazidime and 5.8 (+/- 0.3 SE) mg/l for tobramycin. The peak serum levels of ceftazidime were
Thirty-five neonates with suspected septicaemia were randomized to treatment with tobramycin or ceftazidime, both in combination with ampicillin. Concentrations of antibiotics in the CSF were measured lh after the third, fourth or fifth injection. In 13 of 17 neonates tobramycin CSF concentrations w
Dopamine is frequently used in critically ill newborn infants for treatment of shock and cardiac failure, but its pharmacokinetics has not been evaluated using a specific analytical method. Steady-state arterial plasma concentrations of dopamine were measured in 11 seriously ill infants receiving do